J Korean Soc Hypertens.  2012 Mar;18(1):1-16. 10.5646/jksh.2012.18.1.1.

Clinical Significance of Home Blood Pressure and Its Possible Practical Application

• Imai Y

• KMID: 1966635
• DOI: http://doi.org/10.5646/jksh.2012.18.1.1

Abstract

This review represents the clinical significance of home blood pressure (BP) and its possible practical application. Home BP is highly reproducible and its reproducibility is better than ambulatory BP. According to this feature home BP has a greater prognostic value at least than clinic BP and is extremely effective for the evaluation of drug effects and their duration. The introduction of home BP to the diagnosis and treatment of hypertension facilitates long-term BP control. Home BP is particularly important for the diagnosis and treatment of hypertension in diabetes mellitus, pregnancy, children and renal diseases. Home BP measurements improve the adherence to medications and medical consultations, and are indispensable for diagnosis of white coat hypertension and masked hypertension. Such efficiency of home BP improves medical economy. Home BP can detect minimal charge in BP mediated by medication, and intrinsic and extrinsic stimuli and detect long-term change in BP. Thus, home BP is now indispensable for improvement in the management of hypertension in medical practice as well as for the recognition of hypertension in the general population. Standardization of the measurement procedure may elevate the position of home BP in the practice of diagnosing and treating hypertension.

Keyword

Home blood pressure measurements; Clinical significance; Clinical application; Pharmacology, clinical; Diagnosis; Therapeutics; Hypertension

MeSH Terms

Blood Pressure
Child
Diabetes Mellitus
Fees and Charges
Humans
Hypertension
Masked Hypertension
Pharmacology, Clinical
Pregnancy
Referral and Consultation
White Coat Hypertension

Reference

1. Sakuma M, Imai Y, Nagai K, Watanabe N, Sakuma H, Minami N, et al. Reproducibility of home blood pressure measurements over a 1-year period. Am J Hypertens. 1997. 10(7 Pt 1):798–803.

2. Brueren MM, van Limpt P, Schouten HJ, de Leeuw PW, van Ree JW. Is a series of blood pressure measurements by the general practitioner or the patient a reliable alternative to ambulatory blood pressure measurement?: a study in general practice with reference to short-term and long-term between-visit variability. Am J Hypertens. 1997. 10:879–885.

3. Stergiou GS, Baibas NM, Gantzarou AP, Skeva II, Kalkana CB, Roussias LG, et al. Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacy. Am J Hypertens. 2002. 15(2 Pt 1):101–104.

4. Hernandez-del Rey R, Martin-Baranera M, Sobrino J, Gorostidi M, Vinyoles E, Sierra C, et al. Reproducibility of the circadian blood pressure pattern in 24-h versus 48-h recordings: the Spanish Ambulatory Blood Pressure Monitoring Registry. J Hypertens. 2007. 25:2406–2412.

5. Cuspidi C, Meani S, Salerno M, Valerio C, Fusi V, Severgnini B, et al. Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure. J Hypertens. 2004. 22:273–280.

6. White WB, Larocca GM. Improving the utility of the nocturnal hypertension definition by using absolute sleep blood pressure rather than the "dipping" proportion. Am J Cardiol. 2003. 92:1439–1441.

7. Manning G, Rushton L, Donnelly R, Millar-Craig MW. Variability of diurnal changes in ambulatory blood pressure and nocturnal dipping status in untreated hypertensive and normotensive subjects. Am J Hypertens. 2000. 13:1035–1038.

8. Mochizuki Y, Okutani M, Donfeng Y, Iwasaki H, Takusagawa M, Kohno I, et al. Limited reproducibility of circadian variation in blood pressure dippers and nondippers. Am J Hypertens. 1998. 11(4 Pt 1):403–409.

9. Imai Y, Ohkubo T, Kikuya M, Hashimoto J. Practical aspect of monitoring hypertension based on self-measured blood pressure at home. Intern Med. 2004. 43:771–778.

10. Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens. 2005. 19:801–807.

11. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005. 111:1777–1783.

12. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006. 47:846–853.

13. Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens. 1998. 16:971–975.

14. Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J, et al. How many times should blood pressure be measured at home for better prediction of stroke risk?: ten-year follow-up results from the Ohasama study. J Hypertens. 2004. 22:1099–1104.

15. Asayama K, Ohkubo T, Kikuya M, Metoki H, Hoshi H, Hashimoto J, et al. Prediction of stroke by self-measurement of blood pressure at home versus casual screening blood pressure measurement in relation to the Joint National Committee 7 classification: the Ohasama study. Stroke. 2004. 35:2356–2361.

16. Hozawa A, Ohkubo T, Nagai K, Kikuya M, Matsubara M, Tsuji I, et al. Prognosis of isolated systolic and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home: the Ohasama study. Arch Intern Med. 2000. 160:3301–3306.

17. Asayama K, Ohkubo T, Kikuya M, Metoki H, Obara T, Hoshi H, et al. Use of 2003 European Society of Hypertension-European Society of Cardiology guidelines for predicting stroke using self-measured blood pressure at home: the Ohasama study. Eur Heart J. 2005. 26:2026–2031.

18. Niiranen TJ, Hanninen MR, Johansson J, Reunanen A, Jula AM. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study. Hypertension. 2010. 55:1346–1351.

19. Yasui D, Asayama K, Ohkubo T, Kikuya M, Kanno A, Hara A, et al. Stroke risk in treated hypertension based on home blood pressure: the Ohasama study. Am J Hypertens. 2010. 23:508–514.

20. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004. 291:1342–1349.

21. Niiranen TJ, Johansson JK, Reunanen A, Jula AM. Optimal schedule for home blood pressure measurement based on prognostic data: the Finn-Home Study. Hypertension. 2011. 57:1081–1086.

22. Johansson JK, Niiranen TJ, Puukka PJ, Jula AM. Optimal schedule for home blood pressure monitoring based on a clinical approach. J Hypertens. 2010. 28:259–264.

23. Gaborieau V, Delarche N, Gosse P. Ambulatory blood pressure monitoring versus self-measurement of blood pressure at home: correlation with target organ damage. J Hypertens. 2008. 26:1919–1927.

24. Stergiou GS, Argyraki KK, Moyssakis I, Mastoranto nakis SE, Achimastos AD, Karamanos VG, et al. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension. Am J Hypertens. 2007. 20:616–621.

25. Shimbo D, Pickering TG, Spruill TM, Abraham D, Schwartz JE, Gerin W. Relative utility of home, ambulatory, and office blood pressures in the prediction of end-organ damage. Am J Hypertens. 2007. 20:476–482.

26. Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation. 1997. 95:1464–1470.

27. Leary AC, Donnan PT, MacDonald TM, Murphy MB. The white-coat effect is associated with increased blood pressure reactivity to physical activity. Blood Press Monit. 2002. 7:209–213.

28. Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension. 2000. 36:901–906.

29. Verdecchia P, Angeli F, Gattobigio R, Rapicetta C, Reboldi G. Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension. Am J Hypertens. 2007. 20:154–161.

30. Eguchi K, Ishikawa J, Hoshide S, Pickering TG, Schwartz JE, Shimada K, et al. Night time blood pressure variability is a strong predictor for cardiovascular events in patients with type 2 diabetes. Am J Hypertens. 2009. 22:46–51.

31. Kikuya M, Ohkubo T, Metoki H, Asayama K, Hara A, Obara T, et al. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension. 2008. 52:1045–1050.

32. Parati G, Bilo G. Clinical relevance of day-by-day blood pressure and heart rate variability: new information from homeself-measurements. Hypertension. 2008. 52:1006–1008.

33. Hozawa A, Ohkubo T, Kikuya M, Ugajin T, Yamaguchi J, Asayama K, et al. Prognostic value of home heart rate for cardiovascular mortality in the general population: the Ohasama study. Am J Hypertens. 2004. 17(11 Pt 1):1005–1010.

34. Vaur L, Dubroca II, Dutrey-Dupagne C, Genes N, Chatellier G, Bouvier-d'Yvoire M, et al. Superiority of home blood pressure measurements over office measurements for testing antihypertensive drugs. Blood Press Monit. 1998. 3:107–114.

35. Ragot S, Genes N, Vaur L, Herpin D. Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: feasibility, agreement, and reproducibility of blood pressure response. Am J Hypertens. 2000. 13(6 Pt 1):632–639.

36. Imai Y, Ohkubo T, Hozawa A, Tsuji I, Matsubara M, Araki T, et al. Usefulness of home blood pressure measurements in assessing the effect of treatment in a single-blind placebo-controlled open trial. J Hypertens. 2001. 19:179–185.

37. Menard J, Chatellier G, Day M, Vaur L. Self-measurement of blood pressure at home to evaluate drug effects by the trough: peak ratio. J Hypertens Suppl. 1994. 12:S21–S25.

38. Stergiou GS, Efstathiou SP, Skeva II, Baibas NM, Roussias LG, Mountokalakis TD. Comparison of the smoothness index, the trough: peak ratio and the morning: evening ratio in assessing the features of the antihypertensive drug effect. J Hypertens. 2003. 21:913–920.

39. Omboni S, Fogari R, Palatini P, Rappelli A, Mancia G. Reproducibility and clinical value of the trough-to-peak ratio of the antihypertensive effect: evidence from the sample study. Hypertension. 1998. 32:424–429.

40. Hashimoto J, Chonan K, Aoki Y, Ugajin T, Yamaguchi J, Nishimura T, et al. Therapeutic effects of evening administration of guanabenz and clonidine on morning hypertension: evaluation using home-based blood pressure measurements. J Hypertens. 2003. 21:805–811.

41. Rogers MA, Small D, Buchan DA, Butch CA, Stewart CM, Krenzer BE, et al. Home monitoring service improves mean arterial pressure in patients with essential hypertension: a randomized, controlled trial. Ann Intern Med. 2001. 134:1024–1032.

42. Moller DS, Dideriksen A, Sorensen S, Madsen LD, Pedersen EB. Accuracy of telemedical home blood pressure measurement in the diagnosis of hypertension. J Hum Hypertens. 2003. 17:549–554.

43. Rudd P, Miller NH, Kaufman J, Kraemer HC, Bandura A, Greenwald G, et al. Nurse management for hypertension: a systems approach. Am J Hypertens. 2004. 17:921–927.

44. Logan AG, McIsaac WJ, Tisler A, Irvine MJ, Saunders A, Dunai A, et al. Mobile phone-based remote patient monitoring system for management of hypertension in diabetic patients. Am J Hypertens. 2007. 20:942–948.

45. Parati G, Pickering TG. Home blood-pressure monitoring: US and European consensus. Lancet. 2009. 373:876–878.

46. Nakamoto H, Nishida E, Ryuzaki M, Sone M, Suzuki H, Yoshimoto M, et al. Effect of telmisartan and amlodipine on home blood pressure by monitoring newly developed telemedicine system: monitoring test by using telemedicine. Telmisartan's effect on home blood pressure (TelTelbosu). Clin Exp Hypertens. 2008. 30:57–67.

47. Verberk WJ, Kroon AA, Lenders JW, Kessels AG, van Montfrans GA, Smit AJ, et al. Self-measurement of blood pressure at home reduces the need for antihypertensive drugs: a randomized, controlled trial. Hypertension. 2007. 50:1019–1025.

48. Ryuzaki M, Nakamoto H, Nishida E, Sone M, Nakajima S, Yoshimoto M, et al. Crossover study of amlodipine versus nifedipine CR with home blood pressure monitoring via cellular phone: internet-mediated open-label crossover trial of calcium channel blockers for hypertension (i-TECHO trial). J Hypertens. 2007. 25:2352–2358.

49. Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008. 299:2857–2867.

50. Parati G, Omboni S, Albini F, Piantoni L, Giuliano A, Revera M, et al. Home blood pressure telemonitoring improves hypertension control in general practice: the TeleBPCare study. J Hypertens. 2009. 27:198–203.

51. McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010. 376:163–172.

52. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008. 26:1505–1526.

53. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007. 25:1105–1187.

54. Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D, et al. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008. 52:10–29.

55. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res. 2009. 32:3–107.

56. Halme L, Vesalainen R, Kaaja M, Kantola I. HOme MEasuRement of blood pressure study group. Self-monitoring of blood pressure promotes achievement of blood pressure target in primary health care. Am J Hypertens. 2005. 18:1415–1420.

57. Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ. 2004. 329:145.

58. Zarnke KB, Feagan BG, Mahon JL, Feldman RD. A randomized study comparing a patient-directed hypertension management strategy with usual office-based care. Am J Hypertens. 1997. 10:58–67.

59. Canzanello VJ, Jensen PL, Hunder I. Rapid adjustment of antihypertensive drugs produces a durable improvement in blood pressure. Am J Hypertens. 2001. 14(4 Pt 1):345–350.

60. Cuspidi C, Meani S, Fusi V, Salerno M, Valerio C, Severgnini B, et al. Home blood pressure measurement and its relationship with blood pressure control in a large selected hypertensive population. J Hum Hypertens. 2004. 18:725–731.

61. Staessen JA, Den Hond E, Celis H, Fagard R, Keary L, Vandenhoven G, et al. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial. JAMA. 2004. 291:955–964.

62. Bosworth HB, Olsen MK, Grubber JM, Neary AM, Orr MM, Powers BJ, et al. Two self-management interventions to improve hypertension control: a randomized trial. Ann Intern Med. 2009. 151:687–695.

63. Hozawa A, Shimazu T, Kuriyama S, Tsuji I. Benefit of home blood pressure measurement after a finding of high blood pressure at a community screening. J Hypertens. 2006. 24:1265–1271.

64. Ashida T, Yokoyama S, Ebihara A, Sugiyama T, Fujii J. Profiles of patients who control the doses of their antihypertensive drugs by self-monitoring of home blood pressure. Hypertens Res. 2001. 24:203–207.

65. Bobrie G, Postel-Vinay N, Delonca J, Corvol P. SETHI Investigators. Self-measurement and self-titration in hypertension: a pilot telemedicine study. Am J Hypertens. 2007. 20:1314–1320.

66. Ogedegbe G, Schoenthaler A. A systematic review of the effects of home blood pressure monitoring on medication adherence. J Clin Hypertens (Greenwich). 2006. 8:174–180.

67. van Onzenoort HA, Verberk WJ, Kroon AA, Kessels AG, Nelemans PJ, van der Kuy PH, et al. Effect of self-measurement of blood pressure on adherence to treatment in patients with mild-to-moderate hypertension. J Hypertens. 2010. 28:622–627.

68. Kim J, Han HR, Song H, Lee J, Kim KB, Kim MT. Compliance with home blood pressure monitoring among middle-aged Korean Americans with hypertension. J Clin Hypertens (Greenwich). 2010. 12:253–260.

69. Saito I, Nomura M, Hirose H, Kawabe H. Use of home blood pressure monitoring and exercise, diet and medication compliance in Japan. Clin Exp Hypertens. 2010. 32:210–213.

70. Imai Y, Munakata M, Tsuji I, Ohkubo T, Satoh H, Yoshino H, et al. Seasonal variation in blood pressure in normotensive women studied by home measurements. Clin Sci (Lond). 1996. 90:55–60.

71. Minami J, Ishimitsu T, Kawano Y, Matsuoka H. Seasonal variations in office and home blood pressures in hypertensive patients treated with antihypertensive drugs. Blood Press Monit. 1998. 3:101–106.

72. Rave K, Bender R, Heise T, Sawicki PT. Value of blood pressure self-monitoring as a predictor of progression of diabetic nephropathy. J Hypertens. 1999. 17:597–601.

73. Iwabu A, Konishi K, Tokutake H, Yamane S, Ohnishi H, Tominaga Y, et al. Inverse correlation between seasonal changes in home blood pressure and atmospheric temperature in treated-hypertensive patients. Clin Exp Hypertens. 2010. 32:221–226.

74. Kimura T, Senda S, Masugata H, Yamagami A, Okuyama H, Kohno T, et al. Seasonal blood pressure variation and its relationship to environmental temperature in healthy elderly Japanese studied by home measurements. Clin Exp Hypertens. 2010. 32:8–12.

75. Metoki H, Ohkubo T, Watanabe Y, Nishimura M, Sato Y, Kawaguchi M, et al. Seasonal trends of blood pressure during pregnancy in Japan: the babies and their parents' longitudinal observation in Suzuki Memorial Hospital in Intrauterine Period study. J Hypertens. 2008. 26:2406–2413.

76. Tsubota-Utsugi M, Ohkubo T, Kikuya M, Metoki H, Kurimoto A, Suzuki K, et al. High fruit intake is associated with a lower risk of future hypertension determined by home blood pressure measurement: the OHASAMA study. J Hum Hypertens. 2011. 25:164–171.

77. Ohkubo T, Hozawa A, Nagatomi R, Fujita K, Sauvaget C, Watanabe Y, et al. Effects of exercise training on home blood pressure values in older adults: a randomized controlled trial. J Hypertens. 2001. 19:1045–1052.

78. Seki M, Inoue R, Ohkubo T, Kikuya M, Hara A, Metoki H, et al. Association of environmental tobacco smoke exposure with elevated home blood pressure in Japanese women: the Ohasama study. J Hypertens. 2010. 28:1814–1820.

79. Watanabe Y, Metoki H, Ohkubo T, Hirose T, Kikuya M, Asayama K, et al. Parental longevity and offspring's home blood pressure: the Ohasama study. J Hypertens. 2010. 28:272–277.

80. Watanabe Y, Metoki H, Ohkubo T, Katsuya T, Tabara Y, Kikuya M, et al. Accumulation of common polymorphisms is associated with development of hypertension: a 12-year follow-up from the Ohasama study. Hypertens Res. 2010. 33:129–134.

81. Padmanabhan S, Menni C, Lee WK, Laing S, Brambilla P, Sega R, et al. The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study. J Hypertens. 2010. 28:465–477.

82. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005. 45:142–161.

83. Ugajin T, Hozawa A, Ohkubo T, Asayama K, Kikuya M, Obara T, et al. White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study. Arch Intern Med. 2005. 165:1541–1546.

84. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Polo Friz H, et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension. 2009. 54:226–232.

85. Julius S, Mejia A, Jones K, Krause L, Schork N, van de Ven C, et al. "White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan. Hypertension. 1990. 16:617–623.

86. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation. 2001. 104:1385–1392.

87. Hozawa A, Ohkubo T, Kikuya M, Yamaguchi J, Ohmori K, Fujiwara T, et al. Blood pressure control assessed by home, ambulatory and conventional blood pressure measurements in the Japanese general population: the Ohasama study. Hypertens Res. 2002. 25:57–63.

88. Niiranen TJ, Jula AM, Kantola IM, Reunanen A. Prevalence and determinants of isolated clinic hypertension in the Finnish population: the Finn-HOME study. J Hypertens. 2006. 24:463–470.

89. Shimada K, Fujita T, Ito S, Naritomi H, Ogihara T, Shimamoto K, et al. The importance of home blood pressure measurement for preventing stroke and cardiovascular disease in hypertensive patients: a sub-analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study. Hypertens Res. 2008. 31:1903–1911.

90. Obara T, Ohkubo T, Kikuya M, Asayama K, Metoki H, Inoue R, et al. Prevalence of masked uncontrolled and treated white-coat hypertension defined according to the average of morning and evening home blood pressure value: from the Japan Home versus Office Measurement Evaluation Study. Blood Press Monit. 2005. 10:311–316.

91. Bobrie G, Genes N, Vaur L, Clerson P, Vaisse B, Mallion JM, et al. Is "isolated home" hypertension as opposed to "isolated office" hypertension a sign of greater cardiovascular risk? Arch Intern Med. 2001. 161:2205–2211.

92. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003. 107:1401–1406.

93. Chonan K, Hashimoto J, Ohkubo T, Tsuji I, Nagai K, Kikuya M, et al. Insufficient duration of action of antihypertensive drugs mediates high blood pressure in the morning in hypertensive population: the Ohasama study. Clin Exp Hypertens. 2002. 24:261–275.

94. Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, et al. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005. 46:508–515.

95. Obara T, Ohkubo T, Funahashi J, Kikuya M, Asayama K, Metoki H, et al. Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME study. J Hypertens. 2005. 23:1653–1660.

96. Kawabe H, Saito I, Saruta T. Status of home blood pressure measured in morning and evening: evaluation in normotensives and hypertensives in Japanese urban population. Hypertens Res. 2005. 28:491–498.

97. Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, et al. Relation between nocturnal decline in blood pressure and mortality: the Ohasama Study. Am J Hypertens. 1997. 10:1201–1207.

98. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, et al. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension. 2006. 47:149–154.

99. Kamoi K, Miyakoshi M, Soda S, Kaneko S, Nakagawa O. Usefulness of home blood pressure measurement in the morning in type 2 diabetic patients. Diabetes Care. 2002. 25:2218–2223.

100. Asayama K, Ohkubo T, Kikuya M, Obara T, Metoki H, Inoue R, et al. Prediction of stroke by home "morning" versus "evening" blood pressure values: the Ohasama study. Hypertension. 2006. 48:737–743.

101. Kario K, Ishikawa J, Pickering TG, Hoshide S, Eguchi K, Morinari M, et al. Morning hypertension: the strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens Res. 2006. 29:581–587.

102. Imai Y, Nishiyama A, Sekino M, Aihara A, Kikuya M, Ohkubo T, et al. Characteristics of blood pressure measured at home in the morning and in the evening: the Ohasama study. J Hypertens. 1999. 17:889–898.

103. Kawabe H, Saito I. Determinants of exaggerated difference in morning and evening home blood pressure in Japanese normotensives. Hypertens Res. 2009. 32:1028–1031.

104. Obara T, Ito K, Ohkubo T, Shibamiya T, Shinki T, Nakashita M, et al. Uncontrolled hypertension based on morning and evening home blood pressure measurements from the J-HOME study. Hypertens Res. 2009. 32:1072–1078.

105. Ishikawa J, Kario K, Hoshide S, Eguchi K, Morinari M, Kaneda R, et al. Determinants of exaggerated difference in morning and evening blood pressure measured by self-measured blood pressure monitoring in medicated hypertensive patients: Jichi Morning Hypertension Research (J-MORE) Study. Am J Hypertens. 2005. 18:958–965.

106. Matsui Y, Eguchi K, Shibasaki S, Shimizu M, Ishikawa J, Shimada K, et al. Association between the morning-evening difference in home blood pressure and cardiac damage in untreated hypertensive patients. J Hypertens. 2009. 27:712–720.

107. Shibuya Y, Ikeda T, Gomi T. Morning rise of blood pressure assessed by home blood pressure monitoring is associated with left ventricular hypertrophy in hypertensive patients receiving long-term antihypertensive medication. Hypertens Res. 2007. 30:903–911.

108. Nishinaga M, Takata J, Okumiya K, Matsubayashi K, Ozawa T, Doi Y. High morning home blood pressure is associated with a loss of functional independence in the community-dwelling elderly aged 75 years or older. Hypertens Res. 2005. 28:657–663.

109. Shibamiya T, Obara T, Ohkubo T, Shinki T, Ishikura K, Yoshida M, et al. Electrocardiographic abnormalities and home blood pressure in treated elderly hypertensive patients: Japan home versus office blood pressure measurement evaluation in the elderly (J-HOME-Elderly) study. Hypertens Res. 2010. 33:670–677.

110. Asayama K, Ohkubo T, Hara A, Hirose T, Yasui D, Obara T, et al. Repeated evening home blood pressure measurement improves prognostic significance for stroke: a 12-year follow-up of the Ohasama study. Blood Press Monit. 2009. 14:93–98.

111. Stergiou GS, Nasothimiou EG, Kalogeropoulos PG, Pantazis N, Baibas NM. The optimal home blood pressure monitoring schedule based on the Didima outcome study. J Hum Hypertens. 2010. 24:158–164.

112. Niiranen TJ, Jula AM, Kantola IM, Reunanen A. Comparison of agreement between clinic and home-measured blood pressure in the Finnish population: the Finn-HOME Study. J Hypertens. 2006. 24:1549–1555.

113. Chonan K, Kikuya M, Araki T, Fujiwara T, Suzuki M, Michimata M, et al. Device for the self-measurement of blood pressure that can monitor blood pressure during sleep. Blood Press Monit. 2001. 6:203–205.

114. Hosohata K, Kikuya M, Ohkubo T, Metoki H, Asayama K, Inoue R, et al. Reproducibility of nocturnal blood pressure assessed by self-measurement of blood pressure at home. Hypertens Res. 2007. 30:707–712.

115. Kario K, Hoshide S, Shimizu M, Yano Y, Eguchi K, Ishikawa J, et al. Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protection (J-TOP) study. J Hypertens. 2010. 28:1574–1583.

116. Stergiou GS, Tzamouranis D, Nasothimiou EG, Karpettas N, Protogerou A. Are there really differences between home and daytime ambulatory blood pressure?: comparison using a novel dual-mode ambulatory and home monitor. J Hum Hypertens. 2010. 24:207–212.

117. Nakano H, Kikuya M, Hara A, Nakashita M, Hirose T, Obara T, Metoki H, Inoue R, Asayama K, Ohkubo T, Totsune K, Imai Y. Self-monitoring of ambulatory blood pressure by the Microlife WatchBP O3: an application test. Clin Exp Hypertens. 2011. 33:34–40.

118. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994. 24:793–801.

119. Shimada K, Kawamoto A, Matsubayashi K, Ozawa T. Silent cerebrovascular disease in the elderly: correlation with ambulatory pressure. Hypertension. 1990. 16:692–699.

120. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990. 81:528–536.

121. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002. 20:2183–2189.

122. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens. 1994. 7:23–29.

123. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension: Systolic Hypertension in Europe Trial Investigators. JAMA. 1999. 282:539–546.

124. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegard K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007. 370:1219–1229.

125. Working Party of the International Diabetes Federation (European Region). Hypertension in people with Type 2 diabetes: knowledge-based diabetes-specific guidelines. Diabet Med. 2003. 20:972–987.

126. Obara T, Ohkubo T, Kikuya M, Asayama K, Metoki H, Inoue R, et al. The current status of home and office blood pressure control among hypertensive patients with diabetes mellitus: the Japan Home Versus Office Blood Pressure Measurement Evaluation (J-HOME) study. Diabetes Res Clin Pract. 2006. 73:276–283.

127. Ushigome E, Fukui M, Sakabe K, Tanaka M, Inada S, Omoto A, et al. Uncontrolled home blood pressure in the morning is associated with nephropathy in Japanese type 2 diabetes. Heart Vessels. 2011. 26:609–615.

128. Shea S, Weinstock RS, Starren J, Teresi J, Palmas W, Field L, et al. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus. J Am Med Inform Assoc. 2006. 13:40–51.

129. Pickering TG. Reflections in hypertension: How should blood pressure be measured during pregnancy? J Clin Hypertens (Greenwich). 2005. 7:46–49.

130. Denolle T, Weber JL, Calvez C, Getin Y, Daniel JC, Lurton O, et al. Diagnosis of white coat hypertension in pregnant women with teletransmitted home blood pressure. Hypertens Pregnancy. 2008. 27:305–313.

131. Rey E, Morin F, Boudreault J, Pilon F, Vincent D, Ouellet D. Blood pressure assessments in different subtypes of hypertensive pregnant women: office versus home patient-or nurse-measured blood pressure. Hypertens Pregnancy. 2009. 28:168–177.

132. Terawaki H, Metoki H, Nakayama M, Ohkubo T, Kikuya M, Asayama K, et al. Masked hypertension determined by self-measured blood pressure at home and chronic kidney disease in the Japanese general population: the Ohasama study. Hypertens Res. 2008. 31:2129–2135.

133. Agarwal R, Andersen MJ, Bishu K, Saha C. Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients. Kidney Int. 2006. 69:900–906.

134. da Silva GV, de Barros S, Abensur H, Ortega KC, Mion D Jr. Cochrane Renal Group Prospective Trial Register: CRG060800146. Home blood pressure monitoring in blood pressure control among haemodialysis patients: an open randomized clinical trial. Nephrol Dial Transplant. 2009. 24:3805–3811.

135. Agarwal R. Managing hypertension using home blood pressure monitoring among haemodialysis patients: a call to action. Nephrol Dial Transplant. 2010. 25:1766–1771.

136. Stergiou GS, Nasothimiou E, Giovas P, Kapoyiannis A, Vazeou A. Diagnosis of hypertension in children and adolescents based on home versus ambulatory blood pressure monitoring. J Hypertens. 2008. 26:1556–1562.

137. Furusawa EA, Filho UD, Koch VH. Home blood pressure monitoring in paediatric chronic hypertension. J Hum Hypertens. 2009. 23:464–469.

138. Krakoff LR. Cost-effectiveness of ambulatory blood pressure: a reanalysis. Hypertension. 2006. 47:29–34.

139. McGrath BP. National Blood Pressure Advisory Committee of the National Heart Foundation of Australia. Ambulatory blood pressure monitoring. Med J Aust. 2002. 176:588–592.

140. Rickerby J. The role of home blood pressure measurement in managing hypertension: an evidence-based review. J Hum Hypertens. 2002. 16:469–472.

141. Funahashi J, Ohkubo T, Fukunaga H, Kikuya M, Takada N, Asayama K, et al. The economic impact of the introduction of home blood pressure measurement for the diagnosis and treatment of hypertension. Blood Press Monit. 2006. 11:257–267.

142. Fukunaga H, Ohkubo T, Kobayashi M, Tamaki Y, Kikuya M, Obara T, et al. Cost-effectiveness of the introduction of home blood pressure measurement in patients with office ypertension. J Hypertens. 2008. 26:685–690.

143. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens. 1995. 13(12 Pt 1):1377–1390.

144. Mancia G, Parati G. Clinical significance of "white coat" hypertension. Hypertension. 1990. 16:624–626.

145. Imai Y, Satoh H, Nagai K, Sakuma M, Sakuma H, Minami N, et al. Characteristics of a community-based distribution of home blood pressure in Ohasama in northern Japan. J Hypertens. 1993. 11:1441–1449.

146. Thijs L, Staessen JA, Celis H, Fagard R, De Cort P, de Gaudemaris R, et al. The international database of self-recorded blood pressures in normotensive and untreated hypertensive subjects. Blood Press Monit. 1999. 4:77–86.

147. Staessen JA, Celis H, Hond ED, Giot C, Leeman M, O'Brien E, et al. Comparison of conventional and automated blood pressure measurements: interim analysis of the THOP trial. Treatment of Hypertension According to Home or Office Blood Pressure. Blood Press Monit. 2002. 7:61–62.

148. Fujiwara T, Nishimura T, Ohkuko T, Imai Y. HOMED-BP Study Group. Rationale and design of HOMED-BP Study: hypertension objective treatment based on measurement by electrical devices of blood pressure study. Blood Press Monit. 2002. 7:77–82.